glp 1 and hormone replacement therapy How HRT & GLP-1 Medications work together HRT vs GLP-1 for Weight

doi: 10.1016/j.jacbts.2016.03.011

For most semaglutide users, 5 grams daily is the recommended target unless GI issues require starting lower

In the Phase 3 REDEFINE 1 trial, cagrilintide monotherapy achieved 11.8% average weight loss over 68 weekscomparable to semaglutide but with a notably lower incidence of nausea and vomiting, making it a potential option for patients who dont tolerate GLP-1 medications well

These reports included issues with dosing errors, storage problems during shipping, potential contamination, and the use of unauthorized salt forms with unknown pharmacological properties

No effect was observed there

The comparison with tirzepatide is worth examining carefully, as the dual-agonist approach of tirzepatide may offer additional benefits for some women